Pharma BP

Pharma BP is excited to announce our strategic partnership with FIECON! Together, we are committed to supporting companies to achieve access in the Middle East by offering detailed health economic models that are crucial for securing patient access. With the upcoming Saudi Health Technology Assessment (HTA), the demand for economic models will be higher for companies operating in the region. Our partnership is perfectly positioned to address this need and also marks a pivotal step in our commitment to improving and broadening access to innovative therapies in the Middle East. #PharmaBP #Fiecon #HealthEconomics #MiddleEast #SaudiHTA #PatientAccess #Partnership

Our highly skilled analysts and consultants are accomplished at conducting in-depth primary research, leveraging their expertise to gather valuable insights. We excel in delivering detailed and comprehensive outcomes tailored to meet our clients' needs. The following anecdote, shared by a satisfied client, serves as a testament to the caliber of our services and the effectiveness of our approach in providing impactful solutions. #Consulting #Advisory #MarketResearch #MarketInsights #Pharma

The Ministry of Health (MoH) has unveiled an exciting new collaboration with Open Medical Europe and Farouk, Maamoun Tamer & Co. (Tamer) from Saudi Arabia. This collaboration represents a pivotal advancement in healthcare practices within the Kingdom and is solidified through a Memorandum of Understanding (MOU). These three entities will embark on a groundbreaking pilot program to improve the Perioperative Care Clinical Pathway. This initiative aligns closely with MoH's strategic objectives to enhance the management of surgical waiting lists nationwide. By leveraging innovative approaches in healthcare delivery, including digitalization and process automation, the collaboration aims to streamline and optimize the surgical care journey for patients across Saudi Arabia. #HealthcareInnovation #Collaboration #HealthcareTransformation #SaudiArabia #MinistryofHealth

The Saudi Food and Drug Authority (SFDA - هيئة الغذاء والدواء) has issued updated guidance on the minimum preclinical data requirements for human medicinal and biological products, ensuring the safety and efficacy of pharmaceuticals. This guidance applies to clinical trial applications and marketing authorization/variation applications, including impurity qualification of chemical and biological substances #SFDA #Pharmaceuticals #Biotechnology #Healthcare #Regulations #MedicalDevices #FoodSupplements #Innovation #HealthSafety

News from KSA: Saudi Arabia Expands List of Approved Therapies! Significant update from the months of June and July 2024: The Saudi Food and Drug Authority (SFDA) approved six new therapies. This expansion highlights Saudi Arabia's dedication to offering cutting-edge treatments to its population. #SFDA #SFDAUpdates #NewApprovals #HealthcareInnovation #NewTherapies #Biologics #NCEs 

Unlock key insights into Saudi Arabia's evolving healthcare landscape! Download our comprehensive report to explore the drug approval process, pricing dynamics, procurement processes and the future of access and registration under Vision 2030. Don't miss this essential guide for navigating the Kingdom's healthcare system - Download now! (https://lnkd.in/d-d2HExN)

Explore the groundbreaking results from the ENSEMBLE Phase IIIb study on Ocrelizumab (OCR) for early-stage Relapsing-Remitting Multiple Sclerosis (RRMS). Sponsored by Hoffmann-La Roche, this study showcases the efficacy and safety of the groundbreaking medication in treatment-naive patients. #MultipleScrelosis #MS #Research #Ocrelizumab #ClinicalTrials 

As medicine costs soar and budgets tighten, HTA decisions are more crucial for better resource allocation. A key question becomes how do established HTA agencies like England’s NICE and France’s HAS influence healthcare decisions worldwide? Read our report diving into the impact of their assessments on approval and pricing decisions, with a focus on Saudi Arabia’s SFDA. Download NOW to discover our key findings!(https://lnkd.in/d4awZWNG) #NICE #HAS #SFDA #England #France #SaudiArabia #HTA #Access #Pricing

As we observe National Immunization Awareness Month, it's important to highlight the remarkable strides made in vaccination efforts across the Gulf Cooperation Council (GCC) countries. GCC countries are setting high standards for immunization from the UAE's comprehensive immunization programs to Oman's proactive approach against emerging diseases, the region has shown a strong commitment to protecting public health through robust immunization programs. Let’s explore some of the important initiatives together! #NationalImmunizationAwareness #Vaccination #PublicHealth #ImmunizationInitiatives #GCC

NEW INSIGHTS ALERT! Download our latest Snapshot now! (https://lnkd.in/dBGMkjju) China and Saudi Arabia have been dubbed "emerging markets" within the pharmaceutical industry for a while. Through an assessment of the pharmaceutical industry and healthcare sector in these markets, we explore China and Saudi Arabia's expansion and modernization to answer the key question - have these markets finally emerged? Insights developed in collaboration with expert and consultant Neil Grubert Click this link to download NOW! (https://lnkd.in/dBGMkjju) #EmergingMarkets #Pharmacuetical #Bitechnology #Biotech #China #SaudiArabia